Canada markets closed

Small Pharma Inc. (DMT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1050+0.0050 (+5.00%)
At close: 10:30AM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

    LONDON, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will participate in a fireside chat at the H. C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyon

  • GlobeNewswire

    Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

    Reporting its financial results and continued progress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON, June 09, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, has today published its financial results for the fiscal year ended February 28, 2022. A complete copy of the audited consolida

  • GlobeNewswire

    Small Pharma To Present at the Jefferies Healthcare Conference in New York City on June 10, 2022

    LONDON, May 30, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will present at the Jefferies Healthcare Conference, which is being held from June 8-10 in New York City. Details for the presentation are as follows: Eve